Statins and autoimmune diseases

P. Riboldi, M. Gerosa, Pier Luigi Meroni

Research output: Contribution to journalArticlepeer-review


Besides the well-known lipid-lowering effect, statins display nonlipid-lowering pharmacological activities. In vitro and in vivo studies suggest that statins have direct anti-inflammatory, antithrombotic and plaque-stabilizing effects via a number of mechanisms. A direct immunomodulatory effect has been also demonstrated in in vitro and in vivo experimental models. In addition to traditional risk factors, systemic inflammation, immune-mediated responses and thrombophilia have been suggested to play a major role in sustaining the premature atherosclerosis in autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. This review focuses on the anti-inflammatory and immunomodulating mechanisms of statins as demonstrated in in vitro and in vivo experimental models, providing new insights for the use of statins in treating systemic autoimmune diseases both for their anti-atherosclerotic activity and for their pleiotropic effects on inflammation, haemostasis and the immune responses.

Original languageEnglish
Pages (from-to)765-768
Number of pages4
Issue number9
Publication statusPublished - 2005


  • Atherosclerosis
  • Autoimmune diseases
  • Immunomodulation
  • Inflammation
  • Statins

ASJC Scopus subject areas

  • Immunology
  • Rheumatology


Dive into the research topics of 'Statins and autoimmune diseases'. Together they form a unique fingerprint.

Cite this